Investigation of the effect of rosiglitazaonon asymmetric dimethylargnine levels and dimethylarginine dimethylaminohydrolase activity in acute liver failure

Basit Öğe Kaydı
dc.contributor.authorVardagli, D.
dc.contributor.authorBekpinar, S.
dc.date.accessioned2025-03-26T17:35:08Z
dc.date.available2025-03-26T17:35:08Z
dc.date.issued2014
dc.departmentİstanbul Esenyurt Üniversitesi
dc.descriptionFEBS EMBO 2014 Conference -- AUG 30-SEP 04, 2014 -- Paris, FRANCE
dc.description.abstract[No abstract available]
dc.description.sponsorshipFEBS,EMBO
dc.identifier.endpage577
dc.identifier.issn1742-464X
dc.identifier.issn1742-4658
dc.identifier.scopusqualityQ1
dc.identifier.startpage577
dc.identifier.urihttps://hdl.handle.net/20.500.14704/1039
dc.identifier.volume281
dc.identifier.wosWOS:000359666803402
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofFebs Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250326
dc.subjectacute liver failure; asymmetric dimethylargnine; dimethylarginine dimethylaminohydrolase
dc.titleInvestigation of the effect of rosiglitazaonon asymmetric dimethylargnine levels and dimethylarginine dimethylaminohydrolase activity in acute liver failure
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu